Form 4 for RXRX RECURSION PHARMACEUTICALS, INC.

Accepted 2021-11-19 00:00:00 ET · period of report 2021-11-17 · accession 0001209191-21-065896 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2021-11-19	2021-11-17+	RXRX	Li Dean Y	Dir	S - Sale	$20.15	-19.1K	591.6K	-3%	-$384.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Class A Common Stock	2021-11-19	S	D	13,474	$20.20	578,163	D	—	—	(F3) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.00 to $20.26 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.
2	Common	Class A Common Stock	2021-11-17	S	D	5,626	$20.04	591,637	D	—	—	(F2) The sales price reported herein is a weighted average price. These shares were sold in multiple lots at prices ranging from $20.00 to $20.13 per share. Full sale price information for each lot is available to the Issuer's stockholders and the staff of the U.S. Securities and Exchange Commission upon their written request.